Creative Medical Technology Holdings, Inc. (CELZ)
NASDAQ: CELZ · Real-Time Price · USD
2.070
+0.070 (3.50%)
Dec 20, 2024, 4:00 PM EST - Market closed
CELZ Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Revenue | 0.01 | 0.01 | 0.09 | 0.09 | 0.16 | 0.17 | Upgrade
|
| Revenue Growth (YoY) | -55.28% | -89.84% | 0.96% | -46.65% | -0.60% | 33.04% | Upgrade
|
| Cost of Revenue | 0 | 0 | 0.03 | 0.05 | 0.05 | 0.05 | Upgrade
|
| Gross Profit | 0.01 | 0.01 | 0.06 | 0.04 | 0.11 | 0.12 | Upgrade
|
| Selling, General & Admin | 3.24 | 3.56 | 3.94 | 2.96 | 1.16 | 1.22 | Upgrade
|
| Research & Development | 2.28 | 1.97 | 6.27 | 0.11 | - | - | Upgrade
|
| Operating Expenses | 5.64 | 5.63 | 10.3 | 3.17 | 1.23 | 1.25 | Upgrade
|
| Operating Income | -5.63 | -5.62 | -10.24 | -3.13 | -1.11 | -1.13 | Upgrade
|
| Interest Expense | - | - | - | -4.28 | -1.23 | -1.9 | Upgrade
|
| Interest & Investment Income | 0.31 | 0.33 | 0.1 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | - | 26.03 | -33.98 | -5.09 | Upgrade
|
| EBT Excluding Unusual Items | -5.32 | -5.29 | -10.14 | 18.63 | -36.33 | -8.12 | Upgrade
|
| Other Unusual Items | - | - | - | 0.59 | - | -0.37 | Upgrade
|
| Pretax Income | -5.32 | -5.29 | -10.14 | 19.21 | -36.33 | -8.48 | Upgrade
|
| Net Income | -5.32 | -5.29 | -10.14 | 19.21 | -36.33 | -8.48 | Upgrade
|
| Net Income to Common | -5.32 | -5.29 | -10.14 | 19.21 | -36.33 | -8.48 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 1 | 1 | 0 | 0 | - | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 0 | 0 | - | Upgrade
|
| Shares Change (YoY) | -1.05% | 28.76% | 236.51% | 460.63% | - | - | Upgrade
|
| EPS (Basic) | -3.80 | -3.76 | -9.28 | 73.75 | -626.88 | - | Upgrade
|
| EPS (Diluted) | -3.80 | -3.76 | -9.28 | 56.10 | -626.88 | - | Upgrade
|
| Free Cash Flow | -5.25 | -8.03 | -7.8 | -2.22 | -0.43 | -1.21 | Upgrade
|
| Free Cash Flow Per Share | -3.75 | -5.70 | -7.13 | -6.82 | -7.50 | - | Upgrade
|
| Gross Margin | 60.00% | 60.00% | 67.84% | 45.36% | 69.24% | 72.51% | Upgrade
|
| Operating Margin | -51181.51% | -62445.91% | -11562.50% | -3562.17% | -677.71% | -682.88% | Upgrade
|
| Profit Margin | -48345.28% | -58739.71% | -11449.26% | 21892.75% | -22082.21% | -5126.09% | Upgrade
|
| Free Cash Flow Margin | -47697.63% | -89198.72% | -8800.19% | -2524.99% | -264.17% | -732.99% | Upgrade
|
| EBITDA | -5.52 | -5.53 | -10.15 | -3.03 | -1.05 | -1.1 | Upgrade
|
| D&A For EBITDA | 0.11 | 0.09 | 0.09 | 0.09 | 0.07 | 0.03 | Upgrade
|
| EBIT | -5.63 | -5.62 | -10.24 | -3.13 | -1.11 | -1.13 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.